Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Japan Business Sentiment Hits Four-Year High, Boosting Expectations of BOJ Rate Hike 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Fed Near Neutral Signals Caution Ahead, Shifting Focus to Fixed Income in 2026 
U.S. Stock Futures Mixed as Tech and AI Stocks Face Pressure Ahead of CPI Data 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns 
Bank of Korea Downplays Liquidity’s Role in Weak Won and Housing Price Surge 
Global Markets Slide as Tech Stocks Sink, Yields Rise, and AI Concerns Deepen 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Asian Stocks Slide as AI Valuation Fears and BOJ Uncertainty Weigh on Markets 
Nestle SA said it would be delivering baby formula to the United States from its plants in Switzerland and the Netherlands to help ease up the shortage in U.S. markets. The company announced on Tuesday, May 17, that it will supply Alfamino and Gerber baby formula brands to America.
As per Reuters, parents are panicking as they can no longer find any infant milk formulas in supermarkets as the shelves are always empty these days. The shortage started when Abbott Laboratories, a leading medical devices and health care company in the U.S., recalled several types of its popular baby formula brands, including Similac, EleCare, and Alimnetum.
The milk formula manufacturer issued a recall on the said brands in February following the deaths of two infants who contracted a rare kind of infection. The U.S. Food and Drug Administration (USFDA) carried out an investigation on Abbott and discovered traces of the pathogen Cronobacter sakazakii in its plant in Michigan.
Abbott explained that the said pathogen may have been found in environmental testing during the investigation, but it has not been linked to any infant illness. It also stated that no distributed product was ever tested positive for the presence of any bacteria such as Salmonella Newport and Cronobacter sakasakii, based on the tests. But still, the company still issued the recall due to the complaints it received.
"While Abbott's testing of finished product detected no pathogens, we are taking action by recalling the powder formula manufactured in this facility with an expiration of April 1, 2022, or later," Abbott stated in a press release at that time. "No Abbott liquid formulas, powder formulas, or nutrition products from other facilities are impacted by the recall."
As this incident led to the formula shortage, Nestle will help alleviate the problem by bringing its infant milk formula products to the U.S. the company will be rushing the deliveries as the shortage has now reached the nationwide level.
"We prioritized these products because they serve a critical medical purpose as they are for babies with cow's milk protein allergies," Nestle stated. "Both products (Alfamino and Gerber) were already being imported but we moved shipments up and rushed via air to help fill immediate needs."
Meanwhile, Reckitt Benckiser is also increasing its production of infant formula by 30% to help combat the shortage. It has also upped the frequency of its deliveries to stores and groceries in the U.S.
